Chapter 138 : Evaluation of the Cellular Immune Response in Transplantation

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Evaluation of the Cellular Immune Response in Transplantation, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap138-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap138-2.gif


Mixed leukocyte culture (MLC) is perhaps the most widely used of cellular assays. MLC has been used clinically for donor selection, predominantly for bone marrow transplantation. In contrast to MLC, which measures a bulk response, limiting dilution assay (LDA) is a quantitative tool. contains the thymine kinase enzyme, which interferes with nucleic and amino acid metabolism and subsequently with DNA replication in the contaminated cell culture. In solid-organ transplantation, the histological analysis of allograft biopsies remains the "gold standard" for diagnosing rejection. Since the ultimate goal is the early detection of activated cells infiltrating the allograft and not in vitro priming, it also deals with methods that minimize the possibility of priming against the donor antigens in vitro. Several of the assays outlined in this chapter are being implemented in the clinical laboratory. Researchers compared helper and cytotoxic antirecipient T-cell frequencies in recipients who had received unrelated-donor bone marrow. They found that the helper T lymphocytes (HTLp) and cytotoxic T lymphocytes (CTLp) assays provided similar predictive information for outcome. The HTLp method is more rapid and less labor-intensive and, thus, may be more useful for donor selection in unrelated-donor bone marrow transplantation. A recent multicenter study evaluated the Cylex ImmuKnow assay for the measurement of immune response in immunosuppressed transplant recipients. The long-term goals of using the cellular assays described in this chapter are to assess accurately the changing immuno-logical statuses of transplant recipients, predict long-term graft outcome, and provide the immune response information needed to individualize immunosuppression therapy.

Citation: Reinsmoen N, Zeevi A. 2006. Evaluation of the Cellular Immune Response in Transplantation, p 1228-1243. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch138
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of

Citation: Reinsmoen N, Zeevi A. 2006. Evaluation of the Cellular Immune Response in Transplantation, p 1228-1243. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch138
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Abbas, A. K.,, A. H. Lichtman, and , J. S. Pober. 2000. Cellular and Molecular Immunology, 4th ed. W. B. Saunders Company, Philadelphia, Pa.
2. Ahmed, M.,, R. Venkataraman,, A. Logar,, A. S. Rao,, B. P. Griffith,, R. Keenan., F. S. Dodson,, R. Shapiro,, J. J. Fung, and , A. Zeevi. 2001. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-y inhibition in CD8—and CD8 + peripheral blood T cells. Therapeutic Drug Monitoring 23: 354362.
3. Anderson, U.,, G. Hallden,, U. Persson,, J. Hed,, G. Moller, and , M. Deley. 1988. Enumeration of IFN-γ producing cells by flow cytometry. J. Immunol. Methods 112: 139142.
4. Andreotti, P. E.,, D. Linder,, L. J. Hartman,, G. A. Harel, and , P. H. Thaker. 1993. Bioluminescence and Chemi-luminescence, p. 257. John Wiley & Sons, New York, N.Y.
5. Bach, R. H., and , K. Hirschhorn. 1964. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 143: 813814.
6. Bain, B.,, M. Vas, and , L. Lowenstein. 1964. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 23: 108116.
7. Baker, R. J.,, M. P. Hernandez-Fuentes,, P. A. Brookes,, A. N. Chaudhry,, H. T. Cook, and , R. I. Lechler. 2001. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J. Immunol. 167: 71997206.
8. Billingham, M. 1979. Diagnosis of cardiac rejection by endomyocardial biopsy. J. Heart Transplant 1: 25.
9. Buttgereit, F.,, G. R. Burmester, and , M. D. Brand. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21 (4): 192199.
10. Crouch, S. P. M.,, R. Kozlowski,, K. J. Slater, and , J. Fletcher. 1993. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods. 160: 8188.
11. Crumpton, M. J.,, D. Allan,, J. Auger,, N. M. Green, and , V. C. Maino. 1976. p. 85101. In J. J. Oppenheim and , D. L. Rosenstreich (ed.), Mitogens in Immunobiology. Academic Press, New York, N.Y.
12. Del Prete, G. F.,, M. De Carli,, M. Ricci, and , S. Romagnani. 1991. Helper activity from immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J. Exp. Med. 174: 809813.
13. Duquesnoy, R. J.,, J. D. K. Trager, and , A. Zeevi. 1991. Propagation and characterization of lymphocytes from transplant biopsies. Crit. Rev. Immunol. 10: 455.
14. Ferry, B.,, P. Antrobus,, L. Huzicka,, A. Farrell,, A. Lane, and , H. Chapel. 1997. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin. Exp. Immunol. 110: 410415.
15. Fung, J. J.,, A. Zeevi,, B. Markus,, T. R. Zerbe, and , R. J. Duquesnoy. 1986. Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts. Immunol. Res. 5: 149.
16. Hancock, W. W. 1984. Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol. Rev. 77: 61.
17. Heeger, P. S.,, N. S. Greenspan,, S. Kuhlenschmidt,, C. Dejelo,, C. Hricik,, D. E. Shulak, and , J. A. Tary-Lehman. 1999. Pretransplant frequency of donor-specific IFN gamma producing lymphocytes is a manifestation of immunologic memory and correlates with risk of post transplant rejection episodes. J. Immunol. 163: 22672275.
18. Jung, T.,, U. Schauer,, C. Heusser,, C. Neuman, and , C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159: 197207.
19. Kaminski, E.,, J. Hows,, F. Brookes,, S. Mackinnon,, T. Hughes,, O. Avakian,, C. Sharrock,, J. Goldman, and , J. R. Batchelor. 1989. Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplant. Proc. 21: 29762977.
20. Kaminski, E.,, J. Hows,, S. Man,, P. Brookes,, S. Mackinnon,, T. Hughes,, O. Avakian,, I. M. Goldman, and , J. R. Batchelor. 1989. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48: 608613.
21. Kaufman, C. L.,, A. Zeevi,, R. L. Kormos,, T. R. Zerbe,, R. J. Keenan,, B. F. Uretsky,, B. P. Griffith., R. L. Hardesty, and , R. J. Duquesnoy. 1990. Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum. Immunol. 28: 228.
22. Kirk, A. D.,, M. A. Ibrahim,, R. R. Bolinger, and , O. Finn. 1992. Renal allograft infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Transplantation 53: 329.
23. Kowalski, R.,, D. Post,, M. C. Schneider,, J. Britz,, J. Thomas,, M. Deierhoi,, A. Lobashevsky,, R. Redfield,, E. Schweitzer,, A. Heredian,, C. Davis,, C. Bentlejewski,, J. Fung,, R. Shapiro, and , A. Zeevi. 2003. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin. Transplant. 17: 7788.
24. Lopez-Cabrera, M.,, A. Santis,, E. Fernandez-Ruiz,, R. Blacher,, E. Esch,, P. Sanchez-Mareos, and , E. Sanchez-Madrid. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178: 537547.
25. Lyons, B. 1988. Flow cytometric analysis of cell division by dye dilution, p. In A. Doherty and , K. V. Doherty (ed.), Current Protocols in Cytometry. John Wiley & Sons, Inc., New York, N.Y.
26. Markus, B. H.,, A. J. Demetris,, S. Saidman,, J. J. Fung,, A. Zeevi,, T. E. Starzl, and , R. J. Duquesnoy. 1988. Alloreactive T lymphocytes from liver transplant biopsies: association of HLA specificity with clinicopathological findings. Clin. Transplant. 2: 70.
27. Mayer, T. G.,, A. A. Fuller,, T. C. Fuller,, A. I. Lazarovits,, L. A. Boyle, and , J. Kurnick. 1985. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J. Immunol. 134: 258.
28. Miceli, C.,, T. S. Barry, and , O. J. Finn. 1988. Human allograft derived T-cell lines: donor class I- and class II-directed cytotoxicity and repertoire stability in sequential biopsies. Hum. Immunol. 22: 185198.
29. Mosmann, T. R., and , R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46: 111147.
30. Mosmann, T R., and , R. L. Coffman. 1989. Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145173.
31. Pickler, L. J.,, M. K. Singh,, Z. Zdraveski,, J. R. Treer,, S. L. Waldrop,, P. R. Bergstresser, and , V. C. Maino. 1995. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86: 14081409.
32. Rabinowich, H.,, A. Zeevi,, S. A. Yousem,, I. L. Paradis,, J. H. Dauber,, R. Kormos,, R. Hardesty,, B. P. Griffith, and , R. J. Duquesnoy. 1991. Alloreactivity of lung biopsy and bronchoalveolar lavage derived lymphocytes from pulmonary transplant patients: correlations with acute rejection and bronchiolitis obliterans. Clin. Transplant. 4: 376.
33. Reinsmoen, N. L.,, D. Kaufman,, D. Sutherland,, A. J. Matas,, J. S. Najarian, and , F. H. Bach. 1990. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 50: 783789.
34. Reinsmoen, N. L., and , A. J. Matas. 1993. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity Transplantation 55: 10171023.
35. Reinsmoen, N. L., and , E. M. Mickelson. 1994. HLA-DW typing, p. II.C.3.1II.C.3.9. In A. Nikaein (ed.), American Society for Histocompatibility and Immunogenetics Procedure Manual. American Society for Histocompatibility and Immunogenetics, Lenexa, Kans.
36. Rininsland, F. H.,, T Helms,, R. J. Asaad,, B. O. Boehm, and , M. T. Lehmann. 2000. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J. Immunol. Methods 240: 143155.
37. Saidman, S. L.,, A. J. Demetris,, A. Zeevi, and , R. J. Duquesnoy. 1990. Propagation of lymphocytes infiltrating human liver allografts: correlation with histologic diagnosis of rejection. Transplantation 49: 107112.
38. Sayegh, M. H.,, B. Watschinger, and , C. B. Carpenter. 1994. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 57: 12951302.
39. Schulick, R. D.,, M. B. Weir,, M. W. Miller,, D. J. Cohen,, B. L. Bermas, and , C. M. Shearer. 1993. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation 56: 590596.
40. Schwarer, A. P.,, Y. Z. Jiang,, S. Deacock,, P. S. Brookes,, A. J. Barrett,, J. M. Goldman,, J. R. Batchelor, and , R. I. Lechler. 1994. Comparison of helper and cytotoxic antire-cipient T cell frequencies in unrelated bone marrow transplants. Transplantation 58: 11981203.
41. Sewell, C. W. A.,, E. M. North,, A. D. B. Webster, and , J. Farrant. 1997. Determination of intracellular cytokines by flow cytometry following whole blood culture. J. Immunol. Methods 209: 6774.
42. Shearer, G. M., and , M. Clerici. 1994. In vitro analysis of cell-mediated immunity: clinical relevance. Clin. Chem. 40/11: 21622165.
43. Sottong, P. R.,, J. A. Rosebrock, and , T. R. Kramer. 2000. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin. Diagn. Lab. Immunol. 7: 307311.
44. Valujskikh, A., and , P. S. Heeger. 2000. A closer look at cytokine-secreting T lymphocytes. Graft 3: 250258.
45. Valujskikh, A., and , P. S. Heeger. 2001. Enzyme-linked immunosorbent spot (ELISPOT) assay for detection of alloreactive cytokine-reacting cells—detailed methods. Graft 4: 195201.
46. Van Besouw, N. M.,, B. J. Van Der Mast,, P. De Kuiper,, P. J. H. Smak Gregoor,, L. M. B. Vaessen,, J. N. M. Ijzermans,, T. Van Gelder, and , W. Weimar. 2000. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 70: 136143.
47. Van Buskirk, A. M.,, P. W. Adams, and , C. G. Orosz. 1995. Nonradioactive alternative to clinical mixed lymphocyte reaction. Hum. Immunol. 43: 3844.
48. Van Den Berg, A. P.,, W. N. Twilhaar,, W. J. van Son,, W. vander Bij,, I. J. Klompmaker,, M. J. Sloof,, T. H. The, and , L. H. de Leij. 1998. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin 2 production. Transplantation 65: 10661071.
49. Weber, T.,, C. Kaufman,, A. Zeevi,, T. R. Zerbe,, R. J. Hardesty,, R. H. Kormos,, B. P. Griffith, and , R. J. Duquesnoy. 1989. Lymphocyte growth from cardiac allo-graft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. J. Heart Transplant. 8: 233.
50. Weintraub, D.,, M. Masek, and , M. E. Billingham. 1985. The lymphocyte subpopulations in cyclosporine treated human heart rejection. Heart Transplant. 4: 213.
51. Wells, A. D.,, M. C. Walsh,, D. Sandaran, and , L. A. Turka. 2000. T cell effector function and anergy avoidance are quantitatively linked to cell division. J. Immunol. 165: 24322443.
52. Wier, M. 1996. Rapid assay of cellular immunity in Q fever. Abstr. 96th Gen. Meet. Am. Soc. Microbiol. 1996. American Society for Microbiology, Washington, D.C.
53. Wier, M. L. 1998. Methods for measurement of lymphocyte function. U.S. patent 5,773,232.
54. Zeevi, A.,, J. Fung,, T. R. Zerbe,, C. Kaufman,, B. S. Rabin,, B. P. Griffith,, R. L. Hardesty, and , R. J. Duquesnoy. 1986. Allospecificity of activated T cells grown from endomy-ocardial biopsies from heart transplant patients. Transplantation 41: 620626.
55. Zeevi, A.,, C. Kaufman, and , R. Duquesnoy. 1994. Clinical relevance of lymphocyte analysis in cardiac and pulmonary transplantation, p. 181. In M. Rose and , M. Yacob (ed.), Immunology of Heart and Lung Transplantation. Edward Arnold Publishers, London, United Kingdom.
56. Zeevi, A.,, C. Bentlejewski,, K. Spichty,, K. Griffith,, K. Abu-Elmagd,, N. Hooper,, R. Kowalski, and , J. Fung. 2001. Posttransplant immune monitoring-ATP based assay for T cell activation. One Lambda, Inc., Canoga Park, Calif.
57. Zeevi, A.,, J. Britz,, C. Bentlejewski,, D. Guaspari,, W. Tong,, G. Bond,, H. Murase,, C. Harris,, M. Zak,, D. Martin,, D. Post,, R. Kowalski, and , K. Abu Elmagd. 2005. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl. Immunol. 15: 1724.


Generic image for table

Interpretation of PHA-stimulated sample results

Citation: Reinsmoen N, Zeevi A. 2006. Evaluation of the Cellular Immune Response in Transplantation, p 1228-1243. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch138
Generic image for table

Distribution of results of the Cylex immune cell function assay

Citation: Reinsmoen N, Zeevi A. 2006. Evaluation of the Cellular Immune Response in Transplantation, p 1228-1243. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch138

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error